Clinical trial

Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer

NCT03580395

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-06-01

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2017-06-01Date precision: day

Registry last updated2021-07-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

ApatinibDRUG

paclitaxelDRUG · verified · RxNorm: paclitaxel

cisplatinDRUG · verified · RxNorm: cisplatin

Sponsors & collaborators

Hebei Medical University Fourth Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03580395 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.